Mostrar el registro sencillo

dc.contributor.authorFernández de Larrea Baz, Nereaes_ES
dc.contributor.authorMichel, Angelikaes_ES
dc.contributor.authorRomero, Beatrizes_ES
dc.contributor.authorPérez Gómez, Beatrizes_ES
dc.contributor.authorMoreno, Victores_ES
dc.contributor.authorMartín, Vicentees_ES
dc.contributor.authorDierssen Sotos, Trinidad es_ES
dc.contributor.authorJiménez Moleón, José Juan es_ES
dc.contributor.authorCastilla, Jesúses_ES
dc.contributor.authorTardón García, Adoninaes_ES
dc.contributor.authorRuiz, Irunees_ES
dc.contributor.authorPeiró Pérez, Rosanaes_ES
dc.contributor.authorTejada, Antonioes_ES
dc.contributor.authorChirlaque, María D.es_ES
dc.contributor.authorButt, Julia A.es_ES
dc.contributor.authorOlmedo Requena, Rocíoes_ES
dc.contributor.authorGómez Acebo, Inés es_ES
dc.contributor.authorLinares, Pedroes_ES
dc.contributor.authorBoldo, Elenaes_ES
dc.contributor.authorCastells, Antonies_ES
dc.contributor.otherUniversidad de Cantabriaes_ES
dc.date.accessioned2018-01-17T18:47:09Z
dc.date.available2018-01-17T18:47:09Z
dc.date.issued2017-05-29es_ES
dc.identifier.issn1664-302Xes_ES
dc.identifier.urihttp://hdl.handle.net/10902/12853
dc.description.abstractBackground: Several studies have suggested that Helicobacter pylori (H. pylori) infection is a risk factor for colorectal cancer (CRC), while others have not confirmed this hypothesis. This work aimed to assess the relation of CRC with H. pylori seropositivity and with seropositivity to 16 H. pylori proteins, in the MultiCase-Control study, MCC-Spain. Methods: MCC-Spain is a multicase-control study carried out in Spain from 2008 to 2013. In total, 2,140 histologically-confirmed incident CRC cases and 4,098 population-based controls were recruited. Controls were frequency-matched by sex, age, and province. Epidemiological data were collected through a questionnaire fulfilled by face-to-face interviews and a self-administered food-frequency questionnaire. Seroreactivities against 16 H. pylori proteins were determined in 1,488 cases and 2,495 controls using H. pylori multiplex serology. H. pylori seropositivity was defined as positivity to ?4 proteins. Multivariable logistic regression mixed models were used to estimate odds ratios (OR) and 95% confidence intervals (CI). Results:H. pylori seropositivity was not associated with increased CRC risk (OR = 0.91; 95% CI: 0.71-1.16). Among H. pylori seropositive subjects, seropositivity to Cag? showed a lower CRC risk, and risk decreased with increasing number of proteins seropositive. Seropositivity to the most recognized virulence factors, CagA and VacA, was not associated with a higher CRC risk. No statistically significant heterogeneity was identified among tumor sites, although inverse relations were stronger for left colon cancer. An interaction with age and sex was found: H. pylori seropositivity was associated with a lower CRC risk in men younger than 65 and with a higher risk in older women. Conclusions: Our results suggest that neither H. pylori seropositivity, nor seropositivity to the virulence factor CagA are associated with a higher CRC risk. A possible effect modification by age and sex was identified.es_ES
dc.format.extent12 p.es_ES
dc.language.isoenges_ES
dc.publisherFrontiers Research Foundationes_ES
dc.rightsCC BY © Los autores. This Document is Protected by copyright and was first published by Frontiers. All rights reserved. It is reproduced with permissiones_ES
dc.sourceFront Microbiol. 2017 May 29;8:888es_ES
dc.titleHelicobacter pylori Antibody Reactivities and Colorectal Cancer Risk in a Case-control Study in Spaines_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.identifier.DOI10.3389/fmicb.2017.00888es_ES
dc.type.versionpublishedVersiones_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo